ArticleVirology journal2026

Post-marketing safety profile of bictegravir/emtricitabine/tenofovir alafenamide: a FAERS pharmacovigilance study with EudraVigilance validation and mechanistic investigation of pancreatitis.

Yuxin Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.